Literature DB >> 10783939

Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used?

J De Vries1, A Seebregts, M Drent.   

Abstract

Many studies conducted on the health status and quality of life (QOL) of patients with certain chronic diseases have demonstrated that their disease had an impact on their lives. However, less is known about the QOL and health status of patients suffering from idiopathic pulmonary fibrosis (IPF). In the present study, three focus groups of IPF patients (n=10) were run to identify the aspects of QOL or health status that are relevant to this population and to establish which measure is preferable to assess these aspects. The patients completed and discussed the St. George's Respiratory Questionnaire (SGRQ) and the World Health Organization Quality of Life assessment instrument (WHOQOL-100). Results indicated that hobbies/leisure activities, mobility, transport, social relationships, working capacity, energy and doing things slower were aspects relevant to IPF patients' QOL. The WHOQOL-100, with an additional social support questionnaire, appeared to be preferable.

Entities:  

Mesh:

Year:  2000        PMID: 10783939     DOI: 10.1053/rmed.1999.0736

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  10 in total

Review 1.  Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.

Authors:  J J Swigris; W G Kuschner; S S Jacobs; S R Wilson; M K Gould
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

2.  Palliative Care for Patients Dying in the Intensive Care Unit with Chronic Lung Disease Compared with Metastatic Cancer.

Authors:  Crystal E Brown; Ruth A Engelberg; Elizabeth L Nielsen; J Randall Curtis
Journal:  Ann Am Thorac Soc       Date:  2016-05

3.  Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis.

Authors:  Noah Lechtzin; Marisa E Hilliard; Maureen R Horton
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

4.  Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives.

Authors:  Jeffrey J Swigris; Anita L Stewart; Michael K Gould; Sandra R Wilson
Journal:  Health Qual Life Outcomes       Date:  2005-10-07       Impact factor: 3.186

5.  A qualitative study of informal caregivers' perspectives on the effects of idiopathic pulmonary fibrosis.

Authors:  Amanda Belkin; Karen Albright; Jeffrey J Swigris
Journal:  BMJ Open Respir Res       Date:  2014-01-03

Review 6.  Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis.

Authors:  Amy L Olson; Kevin K Brown; Jeffrey J Swigris
Journal:  Patient Relat Outcome Meas       Date:  2016-05-17

7.  The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

Authors:  Alex Diamantopoulos; Emily Wright; Katerina Vlahopoulou; Laura Cornic; Nils Schoof; Toby M Maher
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

8.  Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: a randomised controlled trial.

Authors:  Silvia Perez-Bogerd; Wim Wuyts; Veronica Barbier; Heleen Demeyer; Alain Van Muylem; Wim Janssens; Thierry Troosters
Journal:  Respir Res       Date:  2018-09-20

9.  An empirical comparison of the WHOQOL-BREF and the SGRQ among patients with COPD.

Authors:  Wen-Miin Liang; Jian-Jung Chen; Chih-Hung Chang; Hung-Wei Chen; Shiah-Lian Chen; Liang-Wen Hang; Jung-Der Wang
Journal:  Qual Life Res       Date:  2008-05-24       Impact factor: 4.147

10.  A New Tool to Assess Quality of Life in Patients with Idiopathic Pulmonary Fibrosis or Non-specific Interstitial Pneumonia.

Authors:  Detlef Kirsten; Ulrike de Vries; Ulrich Costabel; Dirk Koschel; Francesco Bonella; Andreas Günther; Jürgen Behr; Martin Claussen; Stefan Schwarz; Antje Prasse; Michael Kreuter
Journal:  Pneumologie       Date:  2021-09-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.